Cigna Challenges Arbitration Award: Federal Court Ruling Raises Important Questions for Out-of-Network Healthcare Providers

Can a health insurance company challenge an arbitration award after a healthcare provider successfully pursues payment for out-of-network services?

A recent federal court decision involving Cigna and two pathology groups demonstrates that the answer may be yes—and highlights an important legal distinction between state-mandated arbitration, federal ERISA protections, and the enforceability of arbitration awards.

On October 8, 2026, the United States District Court for the Northern District of Illinois issued an order in Cigna Health and Life Insurance Company v. Laboratory Physicians, LLC, Case No. 1:24-cv-01947, permitting part of Cigna’s lawsuit challenging an arbitration award to proceed.

The decision raises important questions for physicians, laboratories, hospitals, and other out-of-network healthcare providers that rely on arbitration to resolve reimbursement disputes.

Importantly, the Court did not invalidate the arbitration award. Instead, it determined that Cigna could proceed with its challenge under the Employee Retirement Income Security Act of 1974 (ERISA), leaving the ultimate enforceability of the award unresolved.

The Dispute: Out-of-Network Pathology Services and Arbitration

The litigation arose from reimbursement disputes involving Cigna and two pathology groups: Laboratory Physicians, LLC, and Winfield Laboratory Consultants, S.C.

Both pathology groups provided services to patients at hospitals that participated in Cigna’s provider network. Although the hospitals were in-network, the pathology groups themselves were out-of-network.

This distinction is significant.

Healthcare providers frequently furnish medically necessary services at participating hospitals without having a direct contractual relationship with a patient’s health insurance company.

When reimbursement disputes arise, providers may have access to state or federal dispute resolution procedures depending on the services, the health plan, and the applicable law.

In this case, both pathology groups initiated arbitration under Section 356z.3a of the Illinois Insurance Code, which establishes a dispute resolution mechanism for certain out-of-network services.

The arbitration proceedings produced different outcomes:

• Laboratory Physicians prevailed in its arbitration against Cigna.
• Winfield Laboratory Consultants did not prevail, with the arbitrator ruling in Cigna’s favor.

Cigna subsequently pursued federal litigation challenging the arbitration proceedings and seeking relief under ERISA.

Cigna’s Argument: ERISA Preemption Limits State Arbitration Authority

At the center of the litigation was Cigna’s argument that the Illinois arbitration statute could not lawfully be applied to claims involving self-funded ERISA health plans.

This distinction matters because not all employer-sponsored health plans are regulated in the same manner.

In a fully insured arrangement, an insurance company generally assumes the financial risk of paying covered claims. In a self-funded arrangement, the employer generally funds covered healthcare expenses, often retaining an insurance company to administer the plan.

ERISA contains broad federal preemption provisions that can restrict the application of state insurance laws to self-funded employee benefit plans.

Cigna argued that the arbitrators exceeded their authority by applying Illinois’ state-mandated arbitration process to claims involving self-funded ERISA plans.

The Court agreed with a central part of that argument.

In its October 8 order, the Court concluded that Section 356z.3a could not be applied to self-funded ERISA plans in the circumstances presented. The Court reasoned that ERISA’s preemption framework prevented Illinois from imposing the state arbitration requirements on those plans.

The Court also concluded that the arbitrators’ exercise of jurisdiction over the self-funded plan claims constituted an improper expansion of their authority.

For healthcare providers, the significance is substantial: An arbitration award may be vulnerable to legal challenge when the underlying dispute resolution process was not legally authorized to adjudicate the claims at issue.

Does Winning Arbitration Guarantee Payment?

Not necessarily.

Healthcare providers often view arbitration as an important mechanism for resolving payment disputes without prolonged litigation.

However, the Cigna decision illustrates that obtaining a favorable arbitration award does not necessarily eliminate subsequent legal challenges.

Cigna argued that the arbitrators lacked jurisdiction over claims involving self-funded ERISA plans. The pathology groups countered that Cigna’s lawsuit amounted to an impermissible collateral attack on the arbitration decisions.

The Court rejected that defense at the motion-to-dismiss stage with respect to the surviving claim.

The Court determined that the alleged jurisdictional defect was sufficiently serious to permit judicial consideration of the challenge.

This does not mean that health insurers may automatically overturn unfavorable arbitration awards.

Nor does it mean that every disagreement over an arbitrator’s interpretation of the law creates grounds for judicial intervention.

Rather, the decision illustrates that a fundamental jurisdictional defect may create an avenue for challenging an award, particularly when federal preemption principles are implicated.

The Court Did Not Invalidate the Entire Arbitration Award

One of the most important aspects of the decision is what the Court did not decide.

Although the Court allowed Cigna’s ERISA challenge concerning the Laboratory Physicians award to proceed, it expressly declined to determine the ultimate validity of that award.

The Court recognized that the arbitration award may have included claims involving self-funded health plans, but the factual record was not sufficiently developed to establish the precise composition of the claims.

Consequently, the Court concluded that it was premature to determine whether some or all of the award was unenforceable.

This distinction is important for providers and payers alike.

A finding that certain claims were improperly subjected to arbitration does not necessarily establish that every claim included in an arbitration award is invalid.

The enforceability of an award may depend on the underlying claims, the applicable plan arrangements, and the legal authority governing each dispute.

What About the Federal No Surprises Act?

Although this case involves out-of-network reimbursement and arbitration, it is important to distinguish the Illinois statutory process from the federal No Surprises Act (NSA).

The NSA establishes a federal independent dispute resolution (IDR) process for certain qualifying out-of-network payment disputes.

The federal IDR framework is distinct from the Illinois arbitration mechanism at issue in this litigation.

The Court’s October 8 decision did not determine the validity of a federal NSA IDR award, nor did it hold that federal NSA arbitration is generally unavailable for self-funded ERISA plans.

Instead, the Court addressed whether Illinois could require self-funded ERISA plans to participate in the particular state-law arbitration process at issue.

That distinction should not be overlooked.

Healthcare providers pursuing reimbursement through the NSA must evaluate the federal statutory and regulatory requirements applicable to those disputes, including eligibility, deadlines, procedural requirements, and enforcement mechanisms.

Providers should not assume that a ruling involving state-mandated arbitration automatically governs federal NSA disputes.

Nevertheless, the case illustrates a broader concern relevant to reimbursement disputes: Before initiating arbitration, providers must determine whether the selected dispute resolution process has legal authority over the claims.

Five Important Lessons for Physicians and Healthcare Providers

1. Determine Whether the Health Plan Is Fully Insured or Self-Funded

The funding arrangement of a health plan may significantly affect which laws govern a reimbursement dispute.

A health insurance company may act as both an insurer for some plans and a third-party administrator for others.

Providers should not assume that every claim administered by the same insurance company is subject to identical state insurance requirements.

1. Confirm That the Arbitration Process Applies

Before initiating arbitration, providers should evaluate whether the claim qualifies under the applicable state or federal dispute resolution framework.

An arbitration proceeding that is unavailable for a particular claim may expose an otherwise favorable award to challenge.

1. Preserve Documentation Supporting the Arbitration Award

Providers should maintain complete records of the reimbursement dispute, including claim submissions, payment determinations, communications, arbitration filings, and the final award.

Where multiple claims are involved, documentation identifying the health plan and funding arrangement associated with each claim may be particularly important.

1. Understand the Difference Between an Arbitration Award and an Enforceable Payment Obligation

A favorable arbitration award is an important legal development, but it may not resolve every potential dispute concerning payment.

Depending on the governing statute and circumstances, additional enforcement proceedings or litigation may become necessary.

Providers should evaluate the legal basis for enforcement rather than assuming that every arbitration award is immune from challenge.

1. Recognize That ERISA Can Change the Legal Analysis

ERISA is not merely an employee benefits statute. Its preemption and enforcement provisions can substantially affect healthcare reimbursement disputes.

For providers seeking payment from employer-sponsored health plans, ERISA may influence the availability of state-law remedies, the applicable dispute resolution process, and the legal arguments available to the parties.

What This Decision Means for Healthcare Reimbursement Disputes

The Cigna litigation illustrates the increasingly complex intersection of state insurance laws, federal ERISA requirements, and healthcare reimbursement arbitration.

It also demonstrates why reimbursement disputes cannot always be approached as routine billing disagreements.

The legal authority of an arbitration forum, the structure of the health plan, and the statutory basis for the provider’s payment rights may all become critical when a payer challenges an award.

For healthcare organizations pursuing substantial reimbursement recoveries, these issues deserve attention before a dispute escalates into litigation.

The central takeaway is straightforward: Winning arbitration is important, but ensuring that the arbitration process is legally applicable and that the resulting award is enforceable is equally important.

How Rivet Health Law Can Help

Rivet Health Law represents healthcare providers in complex reimbursement disputes involving commercial health insurance companies, Medicare, Medicaid, ERISA, and the No Surprises Act.

Our firm focuses on the legal issues that arise when health insurers deny, underpay, delay, or otherwise dispute reimbursement for healthcare services.

We assist physicians, medical groups, hospitals, laboratories, and other healthcare organizations with payer disputes, reimbursement appeals, arbitration-related matters, and litigation.

Healthcare providers facing disputed arbitration awards, out-of-network payment disagreements, or questions involving ERISA and payer reimbursement obligations should carefully evaluate their legal options.

Rivet Health Law helps healthcare providers navigate the legal complexities of reimbursement and pursue payment through the appropriate administrative and judicial processes.

To discuss a healthcare reimbursement dispute, visit www.rivethealthlaw.com.

Case Reference

Cigna Health and Life Insurance Company and Cigna Healthcare, Illinois, Inc. v. Laboratory Physicians, LLC and Winfield Laboratory Consultants, S.C., Case No. 1:24-cv-01947, Document 36 (N.D. Ill. Oct. 8, 2026), Hon. John J. Tharp, Jr.

Disclaimer: This article is provided for general informational purposes and does not constitute legal advice. The applicability of state insurance laws, ERISA, and federal arbitration requirements depends on the particular facts, health plan, services, and governing law. The Court’s October 8, 2026 order addressed a motion to dismiss and did not finally resolve the validity of the Laboratory Physicians arbitration award.